These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2668074)

  • 1. Cells, science and health.
    Petricciani JC
    Dev Biol Stand; 1989; 70():3-10. PubMed ID: 2668074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell line issues: historical and future perspectives.
    Petricciani JC
    Dev Biol Stand; 1992; 76():5-11. PubMed ID: 1478355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyology and tumorigenicity testing requirements: past, present and future.
    Petricciani JC; Horaud FN
    Dev Biol Stand; 1998; 93():5-13. PubMed ID: 9737371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell substrates: lessons learned and challenges remaining.
    Petricciani JC
    Dev Biol Stand; 1999; 100():57-63. PubMed ID: 10616176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acceptability of continuous cell lines: A personal & historical perspective.
    Petricciani JC
    Cytotechnology; 1995 Jan; 18(1-2):9-13. PubMed ID: 22358631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
    Knezevic I; Stacey G; Petricciani J; Sheets R;
    Biologicals; 2010 Jan; 38(1):162-9. PubMed ID: 19818645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety issues relating to the use of mammalian cells as hosts.
    Petricciani JC
    Dev Biol Stand; 1985; 59():149-53. PubMed ID: 3891461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory philosophy and acceptability of cells for the production of biologicals.
    Petricciani JC
    Dev Biol Stand; 1991; 75():9-15. PubMed ID: 1794634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing issues of quality control: diploid and non-diploid cell lines.
    Pearson J
    Dev Biol Stand; 1992; 76():13-7. PubMed ID: 1478333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A history of mammalian embryological research.
    Alexandre H
    Int J Dev Biol; 2001; 45(3):457-67. PubMed ID: 11417885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical considerations and practical concerns regarding the use of continuous cell lines in the production of biologics.
    Petricciani JC; Salk PL; Salk J; Noguchi PD
    Dev Biol Stand; 1981; 50():15-25. PubMed ID: 7341291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell substrates: where do we stand after 50 years of discussion?
    Petricciani J
    Dev Biol (Basel); 2006; 123():11-21; discussion 55-73. PubMed ID: 16566432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of cell substrates used for human biologicals.
    Hayflick L
    Dev Biol Stand; 1989; 70():11-26. PubMed ID: 2668070
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The production of foreign proteins in mammalian cells.
    Bendig MM
    Genet Eng; 1988; (7):91-127. PubMed ID: 3078408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From chloroma to acute promyelocytic leukemia--a historical perspective].
    Schwarz J
    Vnitr Lek; 2008; 54(7-8):686-700. PubMed ID: 18780570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular immortalization process: relevant issues for the generation of cell substrates for production of vaccines and other biologicals.
    Sedivy JM
    Dev Biol (Basel); 2001; 106():479-86; discussion 486-8, 501-11. PubMed ID: 11761263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.